Related Experiment Videos

Acute haemodynamic effects of intravenous administration of trapidil in man

Arzneimittel-Forschung
|January 1, 1985
PubMed

Insights

Trapidil significantly impacts coronary artery disease patients by reducing systemic and pulmonary pressures and vascular resistance. This medication also decreased end-diastolic volume and pressure, improving peripheral and pulmonary circulation.

Area of Science:

  • Cardiology
  • Pharmacology
  • Hemodynamics

Background:

  • Coronary artery disease (CAD) poses significant cardiovascular risks.
  • Understanding the hemodynamic effects of novel therapeutic agents is crucial for managing CAD.

Purpose of the Study:

  • To investigate the hemodynamic effects of trapidil in patients with coronary artery disease.
  • To assess trapidil's impact on systemic and pulmonary circulation.

Main Methods:

  • Six patients with coronary artery disease underwent right and left heart catheterization.
  • Hemodynamic parameters were measured at rest and after intravenous trapidil (100 mg).
  • Left ventricular angiography was performed pre- and post-trapidil administration.

Main Results:

  • Trapidil administration led to increased heart rate.
  • Significant reductions were observed in systemic systolic pressure, pulmonary artery pressure, and systemic/pulmonary vascular resistances.
  • End-diastolic volume and end-diastolic pressure significantly decreased.

Conclusions:

  • Trapidil demonstrates a notable effect on peripheral and pulmonary circulation in CAD patients.
  • The drug's vasodilatory properties may benefit patients with coronary artery disease.

Related Concept Videos